How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,813 results for

Thromboembolic Disease in Pregnancy

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Guidelines on autopsy practice: Autopsy in sickle cell disease and persons with sickle trait

· deep vein thrombosis and pulmonary thromboembolism · dural venous sinus thrombosis and brain haemorrhage · aplastic marrow crisis from parvovirus B19 infection (in children and less commonly in adults). Common pathologies that are less often the direct cause of death: · left ventricular hypertrophy 16 · bone marrow necrosis from painful bony sickle crisis. CEff 050417 7 V4 Final Less common pathologies and scenarios: · posterior reversible encephalopathy syndrome (PRES) 17 · ischaemic heart disease (...) 16 · pregnancy-related with multi-organ failure and ACS, and sepsis · hyperhaemolysis (post-transfusion) syndrome in adults 18 · multi-organ haemosiderosis related to therapeutic/prophylactic blood transfusions; this mainly affects heart, liver, kidney and pancreas · biliary stone diseases: obstructive jaundice, cholecystitis and pancreatitis · overdose of opiate pain-killers: morphine/heroin, pethidine (which also causes seizures), fentanyl patches 19 · gut ulceration and perforation from NSAID

2017 Royal College of Pathologists

122. Adults With Congenital Heart Disease

. Echocardiography 27 3.4.4. CMR Imaging 28 3.4.5. Cardiac Computed Tomography 29 3.4.6. Cardiac Catheterization 30 3.4.7. Exercise Testing 31 3.5. Transition Education 31 3.6. Exercise and Sports 32 3.7. Mental Health and Neurodevelopmental Issues 34 3.8. Endocarditis Prevention 34 3.9. Concomitant Syndromes 35 3.10. Acquired Cardiovascular Disease 36 3.11. Noncardiac Medical Issues 37 3.12. Noncardiac Surgery 37 3.13. Pregnancy, Reproduction, and Sexual Health 39 3.13.1. Pregnancy 39 3.13.2. Contraception 41 (...) Adults With Congenital Heart Disease Accepted Manuscript 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease Karen K. Stout, MD, FACC, Chair, Writing Committee, Curt J. Daniels, MD, Vice Chair, Writing Committee, Jamil A. Aboulhosn, MD, FACC, FSCAI, Writing Committee Member, Biykem Bozkurt, MD, PhD, FACC, FAHA, Writing Committee Member, Craig S. Broberg, MD, FACC, Writing Committee Member, Jack M. Colman, MD, FACC, Writing Committee Member, Stephen R. Crumb, DNP

2018 American College of Cardiology

123. Clinical practice guideline for care in pregnancy and puerperium

disease requiring medication • Liver disease with failure • Thromboembolic disease • Neoplastic disease • HIV infection or hepatitis B virus infection • Cystic Fibrosis • Other serious medical and surgical conditions • Family history of genetic diseases • Physical or mental disability38 CLINICAL PRACTICE GUIDELINES IN THE SNS Obstetrical pathology during pregnancy and the puerperium: • Pregnancy-induced hypertension • Severe anaemia • Gestational Diabetes • Recurrent urinary tract infection (...) creatinine level in a biochemical test? 8. What is the purpose of determining the plasma uric acid level in a biochemical test? 9. What is the purpose of universal screening for syphilis in pregnant women and at what stage of pregnancy should it be done? 10. What is the purpose of universal screening for Chagas disease in pregnant women and at what stage of pregnancy should it be done? 11. What is the purpose of universal screening for chlamydia in pregnant women and at what stage of pregnancy should

2014 GuiaSalud

124. Migraine, cardiovascular disease, and stroke during pregnancy: systematic review of the literature. (PubMed)

, there is an association between an increased risk of ischemic stroke in pregnancy (OR range 7.9 to 30.7), particularly with active migraine. There is also an association between migraine and increased risk of acute myocardial infarction and heart disease (OR 4.9; 95% CI 1.7, 14.2), and thromboembolic events during pregnancy (deep venous thrombosis OR 2.4; 95% CI 1.3, 4.2 and pulmonary embolus OR 3.1; 95% CI 1.7, 5.6).In this review, we summarized the association between migraine and risk of vascular disease during (...) Migraine, cardiovascular disease, and stroke during pregnancy: systematic review of the literature. The objective of this article is to review the literature relating migraine, cardiovascular disease, and stroke during pregnancy in order to better define the relationship between migraines and vascular disease.We conducted a systematic review of the literature using Medline and Cochrane Review with the following search terms: migraine AND pregnancy and vascular disease OR myocardial infarction

2015 Cephalalgia : an international journal of headache

125. Risk of Pulmonary and Venous Thromboembolism in Pregnancies After in Vitro Fertilization

concerning pulmonary embolism (PE). The aim is to estimate and compare the risk of both PE and VTE during the the different phases of pregnancy after IVF to that in age and period matched control women. The investigators will use the Swedish National Health Registers to estimate the risk. Condition or disease Pulmonary Embolism Venous Thromboembolism Detailed Description: Background: Occurrence of venous thromboembolism (VTE) during IVF pregnancies has been reported in numerous case reports and in two (...) Posted: February 2, 2012 Last Verified: January 2012 Keywords provided by Professor Peter Henriksson, Danderyd Hospital: Assisted Reproductive Techniques Pregnancy Pulmonary Embolism Venous Thromboembolism Additional relevant MeSH terms: Layout table for MeSH terms Thromboembolism Embolism Venous Thromboembolism Pulmonary Embolism Embolism and Thrombosis Vascular Diseases Cardiovascular Diseases Lung Diseases Respiratory Tract Diseases

2012 Clinical Trials

126. CT for Pulmonary Thromboembolic Disease

CT for Pulmonary Thromboembolic Disease CT for Pulmonary Thromboembolic Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. CT for Pulmonary Thromboembolic Disease (CT for PE) The safety and scientific (...) Details Study Description Go to Brief Summary: Examine the feasibility and efficacy of individually optimized uniform contrast enhancement in CT pulmonary angiography (CTPA) for the diagnosis of pulmonary thromboembolic disease. Condition or disease Pulmonary Embolism Detailed Description: Patient characteristics, qualitative image quality scores, and quantitative contrast enhancement and CNR will be described using mean values and standard deviations for continuous variables, and frequencies

2014 Clinical Trials

127. Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs

Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs (MYELAXAT) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02066454 Recruitment Status : Unknown Verified

2014 Clinical Trials

128. Prevention and management of venous thromboembolism

thromboembolism 4 2.2 Thromboprophylaxis in surgical patients 4 2.3 Thromboprophylaxis in medical patients 4 2.4 Pregnancy and the puerperium 4 2.5 Diagnosis of venous thromboembolism 5 2.6 Preliminary assessment 5 2.7 Initial management of venous thromboembolism 5 2.8 Further management of venous thromboembolism 5 2.9 Adverse effects of venous thromboembolism prophylaxis and treatment 6 3 a ssessment of risk for venous thromboembolism 7 3.1 Introduction 7 3.2 Clinical assessment of venous thrombosis risk 7 (...) Cerebral vein thrombosis 47 11.6 Splanchnic vein thrombosis 47 r evised n ov. 2011 Prevention and management of venous thromboembolism11.7 Incidental VTE 48 11.8 Pregnancy 48 12 f urther management of venous thromboembolism 49 12.1 Choice of anticoagulant 49 12.2 Graduated elastic compression stockings 51 13 monitoring the anticoagulant effect 52 13.1 Unfractionated heparin 52 13.2 Low molecular weight heparin 52 13.3 Warfarin 52 14 o utpatient management of acute vte 54 14.1 Deep vein thrombosis 54

2010 SIGN

129. Valvular Heart Disease (Focused Update): Guidelines For the Management of Patients With

Valvular Heart Disease (Focused Update): Guidelines For the Management of Patients With CLINICAL PRACTICE GUIDELINE: FOCUSED UPDATE 2017AHA/ACCFocusedUpdateofthe 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, Society (...) disease. The focus is on medical practice in the United States, but guidelines developed in collaboration with other organizations may have a global impact. Although guidelines may be used to inform regulatory or payer decisions, their intent is to improve patients’ quality of care and align with patients’ interests. Guidelines are intendedtode?nepracticesmeetingtheneedsofpatients inmost,butnotall,circumstancesandshouldnotreplace clinical judgment. Clinical Implementation Guideline recommended

2017 American College of Cardiology

130. Heart Disease and Stroke Statistics 2017 Update: A Report From the American Heart Association (Full text)

Cardiac Arrest . . . . . . . . . . . . . . e468 19. Subclinical Atherosclerosis . . . . . . . . . . . . e487 20. Coronary Heart Disease, Acute Coronary Syndrome, and Angina Pectoris. . . . . . . . . . e505 21. Cardiomyopathy and Heart Failure . . . . . . . . e523 22. Valvular Diseases . . . . . . . . . . . . . . . . e539 23. Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism), Chronic Venous Insufficiency, Pulmonary Hypertension. . . e548 24. Peripheral Artery Disease and Aortic (...) , which occurs among 1.0% to 8.8% of those with pulmo- nary embolism. • Assuming 375 000 to 425 000 new cases of venous thromboembolism annually, the overall cost of venous thromboembolism was estimated at $7 billion to $10 billion annually. New Section on Chronic Venous Insufficiency • Varicose veins affect 25 million US adults. More severe venous disease affects 6 million. • Venous ulcer is a substantial morbidity of chronic venous insufficiency. Estimated prevalence in adults is ˜0.3

2017 American Heart Association

131. 2017 Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: A Joint Consensus Document from EHRA and ESC Working Group on Thrombosis

‘valvular AF’ and refer simply to ‘AF related to hemodynamically significant mitral stenosis or prosthetic mechanical heart valves’. AF clearly leads to an incremental risk for thromboembolism in patients with mitral valve stenosis, but there are limited data for other valvular diseases. Another proposal is to use the acronym MARM-AF as a simple acronym to designate ‘Mechanical and Rheumatic Mitral AF’ as an alternative to term ‘valvular AF’ to designate the clinical scenarios for which at the non (...) valves 3.5 High Lillehei-Kaster, Omniscience, Starr-Edwards, Bjork-Shiley and other tilting-disc valves 4.0 * Risk factors: previous thromboembolism; AF; mitral stenosis of any degree; left ventricular ejection fraction < 35%. Reproduced from reference. The duration of antithrombotic therapy also varies according to a number of factors. Lifelong anticoagulant treatment is indicated for all patients with mechanical valves and those with bioprosthetic valves or native valve disease with ≥1 additional

2017 Heart Rhythm Society

132. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

, Yao X, Shah ND, Gersh BJ? Comparative effective- ness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease? Int J Cardiol? 2016;209:181–3? 36? Avezum A, Lopes RD, Schulte PJ, et al? Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial (...) 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines CLINICAL STATEMENTS AND GUIDELINES Circulation. 2017;135:e1159–e1195. DOI: 10.1161/CIR.0000000000000503 June 20/27, 2017 e1159 WRITING GROUP MEMBERS* Rick A. Nishimura, MD, MACC, FAHA, Co-Chair Catherine M. Otto, MD, FACC, FAHA, Co-Chair Robert O. Bonow, MD, MACC

2017 American Heart Association

133. Self-Care for the Prevention and Management of Cardiovascular Disease and Stroke

Simple 7” (ie, smoking cessation, maintenance of body mass index [BMI], physical activity, healthy diet, maintaining low cholesterol, maintaining normal blood pressure [BP], and maintaining normal fasting plasma glucose). These behaviors have been shown to reduce incident stroke, HF, venous thromboembolism, and chronic kidney disease, and even incident cognitive impairment and non‐CVD. Self‐Care as a Decision‐Making Process Self‐care is most commonly understood as a naturalistic decision‐making (...) be addressed early. For example, pregnancy is considered a “natural stress test” that uncovers risk for future CVD among mothers. Women with hypertension or preeclampsia during pregnancy have more than double the risk for a future CVD or cerebrovascular disease death or diagnosis than women who do not have these conditions during pregnancy. LBW among offspring or delivery of a preterm baby place the mother at increased risk for CVD. Early self‐care during this window of opportunity could stave off

2017 American Heart Association

134. CRACKCast E087 – Peripheral Arteriovascular Disease

, MSK shoulder disease, peripheral neuropathies, MS, ETOH abuse, diabetes, and many others! Management depends on the severity and type: Nerve compression only = physio, shoulder rehab, then maybe surgery Arterial compression is a BIG deal: Risk for thrombosis, thromboembolism, acute ischemia, rupture, etc. Acute thrombosis = see the first few questions above. 17) List four anatomic abnormalities associated with thoracic outlet syndrome. See Rosen’s Fig 87-3. Think muscle, ligament, and bone (...) CRACKCast E087 – Peripheral Arteriovascular Disease CRACKCast E087 - Peripheral Arteriovascular Disease - CanadiEM CRACKCast E087 – Peripheral Arteriovascular Disease In , , by Chris Lipp June 26, 2017 This episode of CRACKCast covers Rosen’s Chapter 87, Peripheral Arteriovascular Disease. This episode covers the diagnosis and management of acute and chronic arterial insufficiency, differentiating between thrombotic and embolic insufficiency, as well as aneurysms, AV fistulae, and thoracic

2017 CandiEM

135. The Association of Coloproctology of Great Britain and Ireland Consensus Guidelines in Surgery for Inflammatory Bowel Disease (Full text)

of indications, and including 9850 patients with IBD, the 30‐day incidence of venous thromboembolism was 3.1% in IBD patients. The 30‐day incidence of venous thromboembolism was noted to be higher in patients with ulcerative colitis than in patients with Crohn's disease (4.1% vs 2.1%, P < 0.001). Importantly, the cumulative incidence of venous thromboembolism increased from 1.3% at 7 days to 4.3% at 90 days after surgery in patients with IBD . Rates of postoperative venous thromboembolism are consistently (...) The Association of Coloproctology of Great Britain and Ireland Consensus Guidelines in Surgery for Inflammatory Bowel Disease The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease - Brown - 2018 - Colorectal Disease - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term The full text of this article hosted at iucr.org

2018 Association of Coloproctology of Great Britain and Ireland

136. Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period

diseases during pregnancy , European Heart Journal , 10.1093/eurheartj/ehy340 , 39 , 34 , (3165-3241) , (2018) . Roza Chaireti and Katarina Bremme , Risk Factors, Treatment and Prevention of Venous Thromboembolism During Pregnancy and Postpartum , Embolic Diseases - Unusual Therapies and Challenges , 10.5772/67709 , (2017) . Antonin Zoubian, Laurent Bertoletti and Paul Frappé , After deep vein thrombosis, which patients refer to vascular specialist for anticoagulant withdrawal? A Delphi study results (...) thrombosis and pulmonary embolism in pregnancy and the postpartum period National Women’s Health, Auckland City Hospital, Grafton, Auckland, New Zealand Department of Haematology, Prince of Wales Hospital, Sydney, New South Wales Clinical Haematology Department, Monash Medical Centre, Clayton Australian Centre for Blood Diseases, Monash University, Prahran, Victoria Discipline of Obstetrics and Gynaecology, University of Adelaide, Lyell McEwin Hospital Department of Obstetrics and Gynaecology, Women’s

2012 Clinical Practice Guidelines Portal

137. Hypercapnic respiratory failure during pregnancy due to polymyositis-related respiratory muscle weakness: a case report (Full text)

Hypercapnic respiratory failure during pregnancy due to polymyositis-related respiratory muscle weakness: a case report Polymyositis is a rare medical disorder complicating pregnancy. Ventilatory muscle weakness leading to respiratory failure is an uncommon manifestation of this autoimmune disease. We report a case of life-threatening hypercapnic respiratory failure due to polymyositis-related respiratory muscle weakness in a pregnant woman.A 31-year-old, African woman in her second trimester (...) of pregnancy presented to the emergency department with fever, shortness of breath and muscle weakness. Initial investigations excluded pulmonary infection, thromboembolism, and cardiac dysfunction as the underlying cause of her symptoms. She developed deterioration in her level of consciousness due to carbon dioxide narcosis requiring invasive mechanical ventilation. Further workup revealed markedly elevated serum creatine kinase, abnormal electromyography and edema of her thigh muscles on magnetic

2017 Journal of medical case reports

138. Autoimmune hepatitis and pregnancy: report of two cases with different maternal outcomes (Full text)

Autoimmune hepatitis and pregnancy: report of two cases with different maternal outcomes Women of childbearing age with autoimmune hepatitis (AIH) are now able to get pregnant. The progress of the disease during pregnancy is not well clarified yet. The first pregnant woman had cirrhosis secondary to AIH, and she delivered by cesarean section. The patient had severe thrombocytopenia at the time of hospitalization. Unfortunately, she died due to massive thromboembolism at the 24th hour after (...) delivery. The other patient had three recurrent abortions with a diagnosis of AIH. Low-dose low molecular weight heparin and low-dose acetylsalicylic acid along with low-dose prednisolone were administered during the course of the following pregnancies. The following pregnancies ended up with a living child. There is a high morbidity and mortality risk for both fetus and mother. Hepatic performance of the patients, thrombotic events, inflammatory disorders and autoimmune system activation must

2017 Clinical and Experimental Hepatology

139. The Role of Prothrombin Gene Polymorphism as a Risk Factor for Recurrent Pregnancy Loss

reproductive period) . In 2012, the American Society for Reproductive Medicine Practice Committee issued a statement that defined recurrent pregnancy loss as a disease distinct from infertility defined by two or more failed consecutive pregnancies. Thrombophilia is the tendency to develop thromboses due to inherited defects in the coagulation system. Thrombophilia was identified as a major cause of recurrent pregnancy loss , Because pregnancy is a hypercoagulable state, thromboembolism is the leading cause (...) Committee issued a statement that defined recurrent pregnancy loss as a disease distinct from infertility defined by two or more failed consecutive pregnancies. Condition or disease Intervention/treatment Recurrent Pregnancy Loss Diagnostic Test: polymerase chain reaction Detailed Description: Recurrent miscarriage is a pregnancy loss before 20 weeks of gestation. The recurrent pregnancy loss usually occurring in the first trimester of gestation and its rate is quite high (15-20% even in full

2017 Clinical Trials

140. Physical Activity in Pregnancy

of hypertensive disorders in pregnancy). Condition or disease Pregnancy, Physical Activity Detailed Description: Pregnancy is a natural state of low grade inflammation in the mother and the feto-placental unit. The severity of this inflammation increases with higher pregravid Body Mass Index (BMI). This is reflected by an increase in pro-inflammatory cytokines in the maternal circulation and in the placenta. It has been proposed that the pro-inflammatory maternal and fetal environment plays a role (...) of women who are not physically active, and Group3 consists of women with a risk of hypertensive disorders or metabolic diseases (not diabetes). PA before and in early pregnancy will be assessed with a screening questionnaire. Women reporting a minimum of 150 mins of moderate to vigorous PA per week will be classified as active, women with less PA will be classified as inactive. 20 women each group will be recruited not later than 14 weeks of gestation. Women will be recruited at the outpatient clinic

2017 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>